Ensuring Optimal Clinical Benefit From Oral SERD Therapy in Patients With HR+/HER2- Breast Cancer

Get up to date on the use of oral selective estrogen receptor degraders (SERDs) for the management of HR-positive/HER2-negative metastatic breast cancer through downloadable slides from a live webinar, expert-led interactive case challenges, commentaries, podcasts, and a downloadable PDF to use when counseling patients on oral SERD therapy.

Share

Program Content

Activities

Oral SERDs in BC
Ensuring Optimal Clinical Benefit From Oral SERD Therapy in Patients With HR+/HER2- Breast Cancer
Video
Congratulations: You achieved a completion on 04/09/2022

Released: March 07, 2024

Expires: March 06, 2025

Activities

Individualizing Oral SERD Therapy
Individualizing Therapy for Metastatic Breast Cancer: Oral SERD Therapy
Case Challenge
Congratulations: You achieved a completion on 04/09/2022

Released: May 28, 2024

Expires: May 27, 2025

AEs With Oral SERDs
Managing Adverse Events With Oral SERD Therapy and Promoting Treatment Adherence and Persistence
Case Challenge
Congratulations: You achieved a completion on 04/09/2022

Released: June 11, 2024

Expires: June 10, 2025

Activities

Oral SERDs in Breast Cancer
A Focus on Oral SERDs in Patients With HR+/HER2- Breast Cancer: Avoiding Early Discontinuation
Clinical Thought
Congratulations: You achieved a completion on 04/09/2022

Released: March 27, 2024

Expires: March 26, 2025

Activities

Oral SERDs for mBC
Experiences With Oral SERDs for HR+/HER2- Metastatic Breast Cancer
Podcast Episodes
Congratulations: You achieved a completion on 04/09/2022

Released: May 14, 2024

Expires: May 13, 2025

Activities

SERDs in BC
Ensuring Optimal Clinical Benefit From Oral SERD Therapy in Patients With HR+/HER2- Breast Cancer
Slideset
Congratulations: You achieved a completion on 04/09/2022

Released: February 23, 2024

Expires: February 22, 2025

Activities

Oral SERD AEs
Side Effects of Oral SERD Therapy: What to Expect and When to Call Your Doctor
PDF
Congratulations: You achieved a completion on 04/09/2022

Released: February 21, 2024

Faculty

cover img faculity

Manali Bhave, MD

Phase I Medical Director
Assistant Professor
Department of Hematology & Medical Oncology
Winship Cancer Institute
Emory University
Atlanta, Georgia

cover img faculity

La-Urshalar B. Brock, FNP-BC, CNM, RNFA

Breast/GYN Oncology Nurse Practitioner
Winship Cancer Institute of Emory University
Atlanta, Georgia

cover img faculity

Allison Butts, PharmD, BCOP

Clinical Pharmacy Specialist, Breast Oncology
Pharmacist Manager, Oncology
Program Director, PGY2 Hematology/Oncology Pharmacy Residency
UK Healthcare
Lexington, Kentucky

cover img faculity

Jamie L. Carroll, APRN, CNP, MSN

Assistant Professor of Medical Oncology
Mayo Clinic
Rochester, Minnesota

cover img faculity

Annalise Labatut, PharmD, BCOP

Oncology Clinical Pharmacy Specialist – Breast Oncology
Emory Healthcare/Winship Cancer Institute
Atlanta, Georgia

cover img faculity

Marla Lipsyc-Sharf, MD

Health Sciences Clinical Instructor of Medicine
Division of Hematology/Oncology
UCLA David Geffen School of Medicine
Los Angeles, California

Provided by

ProCE Banner

Provided by Clinical Care Options, LLC, in partnership with Practicing Clinicians Exchange and ProCE, LLC.

Supporters

This activity is supported by an educational grant from Lilly.

Lilly

Partners

Practicing Clinicians Exchange

ProCE Banner

ProCE, LLC

ProCE Banner